Kurt Schrader: “We cannot expect these communities to live with this uncertainly any longer.”

The BIOSIM Act is a commonsense approach to increase the utilization of biosimilars in this country.

We need to offer a more consistent way of providing this critical service to all our small ports.

That prescription drug bill is an excellent, excellent balance between H.R. 3 and what others would perhaps like to do.

The rising cost of drug prices is deeply impacting all Americans. It is time to move forward with policies that have broad support.